European Medical Solutions

Informe acción ENXTBR:ALEMS

Capitalización de mercado: €28.3m

European Medical Solutions Resultados de beneficios anteriores

Pasado controles de criterios 0/6

European Medical Solutions has been growing earnings at an average annual rate of 52.3%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been growing at an average rate of 51.4% per year.

Información clave

52.3%

Tasa de crecimiento de los beneficios

84.4%

Tasa de crecimiento del BPA

Crecimiento de la industria Biotechs -3.6%
Tasa de crecimiento de los ingresos51.4%
Rentabilidad financiera-10.6%
Margen neto-2.4%
Última actualización de beneficios30 Jun 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Would DMS Imaging (EBR:ALIMG) Be Better Off With Less Debt?

Jun 15
Would DMS Imaging (EBR:ALIMG) Be Better Off With Less Debt?

DMS Imaging SA (EBR:ALIMG) Soars 29% But It's A Story Of Risk Vs Reward

Dec 21
DMS Imaging SA (EBR:ALIMG) Soars 29% But It's A Story Of Risk Vs Reward

DMS Imaging SA's (EBR:DMSIM) Subdued P/S Might Signal An Opportunity

Jun 15
DMS Imaging SA's (EBR:DMSIM) Subdued P/S Might Signal An Opportunity

Here's Why DMS Imaging (EBR:DMSIM) Can Manage Its Debt Responsibly

Dec 29
Here's Why DMS Imaging (EBR:DMSIM) Can Manage Its Debt Responsibly

Desglose de ingresos y gastos

Cómo gana y gasta dinero European Medical Solutions. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

ENXTBR:ALEMS Ingresos, gastos y beneficios (EUR Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
30 Jun 2444-1130
31 Mar 2443-1130
31 Dec 2343-1120
30 Sep 2341-1120
30 Jun 2340-1120
31 Mar 2338-3120
31 Dec 2237-6110
30 Sep 2266-7190
30 Jun 2257-4170
31 Mar 2248-2140
31 Dec 21380110
30 Sep 210210
30 Jun 210010
31 Mar 210-110
31 Dec 200-110
30 Sep 200-524
30 Jun 200-927
31 Mar 201-12310
31 Dec 191-16414
30 Sep 191-16313
30 Jun 191-17313
31 Mar 191-16312
31 Dec 181-14310
30 Sep 181-12310
30 Jun 181-1139
31 Mar 181-11210
31 Dec 171-12211
30 Sep 171-12211
30 Jun 172-12212
31 Mar 172-12212
31 Dec 162-12212
30 Sep 161-12211
30 Jun 160-12111
31 Mar 160-1019
31 Dec 150-817
31 Dec 140-413
31 Dec 130-212

Ingresos de calidad: ALEMS is currently unprofitable.

Margen de beneficios creciente: ALEMS is currently unprofitable.


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: ALEMS is unprofitable, but has reduced losses over the past 5 years at a rate of 52.3% per year.

Acelerando crecimiento: Unable to compare ALEMS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Beneficios vs. Industria: ALEMS is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-20.8%).


Rentabilidad financiera

Alta ROE: ALEMS has a negative Return on Equity (-10.58%), as it is currently unprofitable.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado